Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$180M |
| 2 |
BHI
Baker Hughes
BHI
|
+$173M |
| 3 |
Dominion Energy
D
|
+$161M |
| 4 |
Kinder Morgan
KMI
|
+$155M |
| 5 |
Marathon Petroleum
MPC
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$177M |
| 2 |
SLB Ltd
SLB
|
+$121M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$119M |
| 4 |
PepsiCo
PEP
|
+$110M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.14% |
| 2 | Healthcare | 12.64% |
| 3 | Financials | 8.59% |
| 4 | Utilities | 7.75% |
| 5 | Technology | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGNT
1126
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $6.44M | 0.02% |
206,963
-198,836
| -49% | -$5.39M |
|
1127
PUT
lululemon athletica
LULU
$13.9B
| $6.44M | 0.02% |
153,200
+27,900
| +22% | +$1.12M |
|
1128
Greif
GEF
$4.89B
| $6.43M | 0.02% |
146,812
+137,203
| +1,428% | +$6.85M |
|
1129
Vanda Pharmaceuticals
VNDA
$322M
| $6.43M | 0.02% |
619,579
+359,372
| +138% | +$4.71M |
|
|
RXDX
1130
DELISTED
Ignyta, Inc.
RXDX
| $6.42M | 0.02% |
796,870
-45,542
| -5% | -$366K |
|
1131
KBR
KBR
$4.75B
| $6.42M | 0.02% |
+341,014
| New | +$7.4M |
|
1132
Constellation Brands
STZ
$23.5B
| $6.42M | 0.02% |
73,639
-63,356
| -46% | -$5.51M |
|
|
WIN
1133
DELISTED
Windstream Holdings Inc
WIN
| $6.42M | 0.02% |
+75,977
| New | +$6.51M |
|
|
NBSE
1134
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $6.41M | 0.02% |
2,212
-408
| -16% | -$1.35M |
|
1135
Melco Resorts & Entertainment
MLCO
$2.08B
| $6.4M | 0.02% |
243,383
+111,369
| +84% | +$3.36M |
|
1136
iShares Russell 1000 Value ETF
IWD
$84.3B
| $6.39M | 0.02% |
+63,800
| New | +$6.46M |
|
1137
A.O. Smith
AOS
$8.52B
| $6.36M | 0.02% |
269,164
-55,890
| -17% | -$1.36M |
|
1138
State Street SPDR S&P 500 ETF Trust
SPY
$819B
| $6.36M | 0.02% |
32,281
-84,415
| -72% | -$16.7M |
|
1139
Strategy Inc
MSTR
$48.7B
| $6.36M | 0.02% |
485,920
+275,780
| +131% | +$3.84M |
|
1140
Coty
COTY
$2.46B
| $6.34M | 0.02% |
382,875
-416,727
| -52% | -$7.27M |
|
1141
Sensata Technologies
ST
$6.11B
| $6.3M | 0.02% |
141,560
-159,033
| -53% | -$7.54M |
|
1142
AtriCure
ATRC
$2.51B
| $6.3M | 0.02% |
427,759
+9,597
| +2% | +$153K |
|
|
ATRS
1143
DELISTED
Antares Pharma, Inc.
ATRS
| $6.3M | 0.02% |
3,440,975
-626,506
| -15% | -$1.37M |
|
|
PCL
1144
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
| $6.29M | 0.02% |
161,353
+133,559
| +481% | +$5.57M |
|
|
OSG
1145
Octave Specialty Group
OSG
$204M
| $6.29M | 0.02% |
284,690
-90,889
| -24% | -$2.14M |
|
1146
iShares Core S&P 500 ETF
IVV
$891B
| $6.29M | 0.02% |
31,728
+23,767
| +299% | +$4.73M |
|
1147
Charles River Laboratories
CRL
$14.3B
| $6.28M | 0.02% |
105,143
-79,954
| -43% | -$4.57M |
|
|
AFSI
1148
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $6.26M | 0.02% |
314,470
+114,414
| +57% | +$2.42M |
|
|
SMA
1149
DELISTED
SYMMETRY MEDICAL INC
SMA
| $6.25M | 0.02% |
619,544
+489,135
| +375% | +$4.53M |
|
|
SLXP
1150
CALL
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $6.25M | 0.02% |
40,000
+2,800
| +8% | +$406K |
|
Similar funds
Israel Englander's Q3 2014 Portfolio in Review
As of Q3 2014, Israel Englander held 4,400 positions worth $39.5B, up 9.5% from $36.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander deployed $4.94B of net new capital in Q3 2014, opening 1,066 new positions and adding to 1,336 existing holdings. Its largest new stake was St Jude Medical: 1,407,737 shares worth $84.6M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was SLB Ltd, an estimated $121M trimmed.
- Israel Englander's largest Q3 2014 buy was St Jude Medical: 1,407,737 shares worth $84.6M.
- Israel Englander added most to Marathon Oil Corporation in Q3 2014, an estimated $180M increase.
- Israel Englander's biggest Q3 2014 reduction was SLB Ltd, cutting an estimated $121M.
- Israel Englander fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 11% of its $39.5B portfolio in Q3 2014.
- Israel Englander opened 1,066 new positions and closed 749 in Q3 2014.
- Israel Englander's portfolio value rose 9.5% quarter-over-quarter to $39.5B.
Based on Millennium Management's 13F filing for Q3 2014, filed 14 Nov 2014.